Skip to content
Subscriber Only

Merck’s Fosamax Didn’t Cause Jaw Disease, Jury Is Told

Merck & Co.’s osteoporosis drug Fosamax didn’t cause so-called jaw death in a Pennsylvania woman, because the drug doesn’t cause the disease and the woman never had it, a lawyer for the company told a jury.

The company’s attorney, Christy D. Jones, made her closing arguments today in Atlantic City, New Jersey, at the close of the first state-court trial over the drug. Alison Rosenberg, 67, sued claiming she developed osteonecrosis of the jaw as a result of taking Fosamax.